Using Twizzlers to screen for gestational diabetes
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
This study is testing if eating 10 Twizzlers can be a good way to check for gestational diabetes in pregnant women, instead of the usual sugary drink.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 617 (estimated) |
| Ages | 18 Years to 64 Years |
| Sex | Female |
| Sponsor | Baylor College of Medicine Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT02610179 on ClinicalTrials.gov |
What this trial studies
This prospective trial aims to evaluate the effectiveness of consuming 10 Twizzlers as an alternative to the standard 50 gram glucola beverage for screening gestational diabetes mellitus (GDM) in pregnant women. Participants will be recruited from the Harris Health System Obstetrics Clinics and will have their blood glucose levels measured one hour after consuming the Twizzlers. The study will compare the sensitivity, specificity, and predictive values of the Twizzlers challenge against the glucola beverage, providing insights into a potentially cost-effective screening method for GDM. The trial will also assess the need for follow-up glucose tolerance tests based on the results of the screenings.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women between 24 to 28 weeks of gestation who are willing to participate.
Not a fit: Patients with known Type I or Type II diabetes, those on corticosteroids, or those with a previous high glucola screening result will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more palatable and cost-effective method for screening gestational diabetes, improving patient compliance and outcomes.
How similar studies have performed: While the use of alternative screening methods for gestational diabetes is not widely tested, this approach is novel and could provide new insights into effective screening practices.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant * 24 to 28 weeks gestation * Singleton or twin or triplet gestation * Willing to participate in the study Exclusion Criteria: * Known Type II DM * Known Type I DM * On oral or injectable corticosteroids * 50 gram glucola beverage GCT of greater than or equal to 190 mg/dl
Where this trial is running
Houston, Texas
- Ben Taub General Hospital — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Kjersti Aagaard, MD, PhD — Baylor College of Medicine
- Study coordinator: Kjersti Aagaard, MD, PhD
- Email: aagaardt@bcm.edu
- Phone: 713-798-8467
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.